Anthony W. Tolcher - South Texas Accelerated Research Therapeutics (START) Center for Cancer Care

R. Berger,A.W. Tolcher,T.B. Dorff, S. Okubo, L.S. Abraham, R. Reilly, C. Stevenson, S. Wang, J. Arnold, S.R. Mudd, S. Alaei, J. Hong,D.I. Quinn, F. Saad,J. Powderly

Annals of Oncology（2024）

Cited0Views0Bibtex

669P CBX-12-101: Final Results of a Phase I Study of CBX-12, a Peptide Drug Conjugate (PDC) in Patients (pts) with Metastatic Solid Tumors

P. Lorusso,F. Meric-Bernstam,N. Hafez, I.I. Rodriguez Rivera,D. Tripathy, S. Wilks, P. Pearson,M.N. Needle,A.W. Tolcher

Annals of Oncology (2024): S525

Cited0Views0Bibtex

PF-06952229, a Selective TGF-β-R1 Inhibitor: Preclinical Development and a First-in-human, Phase I, Dose-Escalation Study in Advanced Solid Tumors

T. A. Yap,A. D. Choudhury,E. Hamilton, L. S. Rosen, K. L. Stratton, M. S. Gordon, D. Schaer, L. Liu, L. Zhang, R. K. Mittapalli, W. Zhong, N. Soman,A. W. Tolcher

ESMO OPENno. 9 (2024)

Cited2Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn